Alcyomics

United Kingdom
Newcastle upon Tyne, England, United Kingdom, NE2 4HH

Company profile

Alcyomics company profile

Alcyomics offers human in vitro (lab-based) pre-clinical safety testing to ensure drug safety and efficacy before first administration into man. They offer a consultancy service of how the pre-clinical data can be used to assist clinical trial development such as dose response and a stratified medicine approach to patient selection. Their technology is also a suitable alternative to animal testing for the cosmetics industry. In addition They offer immunogenicity and potency testing of novel chemicals. Alcyomics was founded in 2007 and started trading in 2009, providing technology support to the biotechnology, pharmaceutical and cosmetic industries, building on 30 years' research experience with the use of skin explant assays for predicting graft versus host disease and understanding its immunobiology.

Business identity

Contact email
[email protected]
Phone number
+44 191 208 6545
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2007-01-01, Year

Headquarters

Postal code
NE2 4HH
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$370,587
Last funding
Seed / $370,587 / 2016-12-21
Last equity funding
Seed / $370,587
Investors
1
Founders
1
Articles
4

Founders and investors

Founders

Anne Dickinson

Investors

Northstar Ventures